Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd.

SHPHF
Sihuan Pharmaceutical Holdings Group Ltd.US flagOther OTC
0.12
USD
- -
- -
1.09BMarket Cap
Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF
(Other OTC)

Recent

price

0.12

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.13
0.22
0.29
0.25
0.3
0.31
0.31
0.29
0.31
0.3
0.26
0.32
0.23
0.2
0.21
0.29
Revenue per Share
0.07
0.08
0.09
0.12
0.16
0.2
0.17
0.15
0.17
-0.29
0.05
0.04
-0.21
-0.01
-0.02
0.02
Basic EPS, GAAP
0.03
0.03
0.02
0.04
0.1
0.09
0.16
0.15
0.15
0.08
-0.04
-0.01
-0.06
-0.01
0.01
-0.02
Free Cash Flow per Basic Share
0.02
0.05
0.06
0.05
0.02
0.03
0.06
0.12
0.03
0.02
0.15
0.01
0.14
0.03
0.02
0.01
Dividend per Share
0.84
0.12
0.14
0.21
0.34
0.52
0.63
0.72
0.87
0.56
0.46
0.49
0.15
0.11
0.06
0.07
Book Value per Share
0.81
0.38
0.33
0.49
0.64
0.81
0.8
0.75
0.83
1
1
0.9
0.54
0.47
0.44
0.65
Tangible Book Value per Share
8,011
10,364
10,350
10,350
10,363
10,364
10,141
9,483
9,471
9,468
9,466
9,431
9,330
9,297
9,266
9,121
Basic Weighted Avg Shares
1,037
2,242
3,043
2,586
3,084
3,167
3,186
2,746
2,917
2,878
2,464
3,038
2,181
1,861
1,901
2,618
Sales/Revenue/Turnover
59.15
44.5
33.89
57.04
61.55
64.84
58
51.61
57.26
46.93
18.22
21.32
-25.41
-10.29
-24.3
14.33
Operating Margin (%)
36
95
132
196
209
263
291
297
307
355
278
309
370
226
258
225
Depreciation Expense
522
824
904
1,285
1,671
2,062
1,708
1,449
1,620
-2,753
473
417
-1,915
-54
-217
180
Net Income, GAAP
20.18
23.43
20.93
19.39
18.74
28.04
21.96
14.47
16.54
- -
28.6
51.03
- -
- -
- -
55.56
Effective Tax Rate (%)
50.35
36.75
29.73
49.68
54.19
65.12
53.62
52.77
55.53
-95.66
19.21
13.71
-87.79
-2.9
-11.4
6.86
Profit Margin (%)
5,931
3,333
2,171
3,320
3,933
4,513
4,156
2,871
3,528
4,044
3,961
5,240
4,017
2,097
2,407
2,963
Working Capital
- -
6
6
6
4
8
- -
- -
95
15
362
876
929
957
759
735
LT Debt
6,660
6,994
7,187
7,937
9,406
11,192
10,971
11,336
12,774
9,942
9,949
9,150
5,640
5,137
4,949
6,900
Total Equity
12.59
11
10.63
14.42
17.21
14.04
12.75
10.64
11.36
- -
3.1
3.02
- -
- -
- -
2.41
Return on Invested Capital (%)
13.86
21.28
49.69
53.3
53.62
45.41
28.91
20.54
19.65
- -
7.61
10.55
- -
- -
- -
10.84
Return on Capital (%)
14.27
20.81
67.92
71.32
58.4
46.28
29.03
21.92
21.52
-40.53
9.75
9.25
-63.76
-4.49
-27.1
28.65
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-2.76%
-3.91%
39.42%
Free Cash Flow
-39.04%
-50.82%
-342.92%
Net Income, GAAP
-95.85%
-110.16%
-182.94%
Sales/Revenue/Turnover
-0.24%
4.06%
37.71%
Total Cash Common Dividend
144.81%
142.47%
-48.67%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,861
2024
- -
- -
- -
- -
1,901
2025
- -
- -
- -
- -
2,618

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.01
2024
- -
- -
- -
- -
-0.02
2025
- -
- -
- -
- -
0.02

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.03
2024
- -
- -
- -
- -
0.02
2025
- -
- -
- -
- -
0.01
Business
The search did not yield specific recent major changes or detailed product information for Sihuan Pharmaceutical Holdings Group Ltd. I will now focus on directly searching for information on Sihuan Pharmaceutical Holdings Group Ltd. (Ticker: SHPHF) including its latest corporate updates, product details, services, geographic operations, and recent strategic developments.